Analyze Diet

Topic:Pharmacokinetics

Pharmacokinetics in horses involves the study of how drugs are absorbed, distributed, metabolized, and excreted in equine species. This field of study provides insights into the time course of drug concentrations within the horse's body and helps in understanding the effects of various pharmaceuticals. Key parameters in equine pharmacokinetics include absorption rates, bioavailability, half-life, and clearance. These parameters can vary significantly due to factors such as age, breed, and health status of the horse. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacokinetic profiles of different drugs in horses, aiming to optimize dosing regimens and improve therapeutic outcomes in equine medicine.
Preface. Antiparasitic drug use and resistance in cattle, small ruminants and equines in the United States–current status and global perspectives.
Veterinary parasitology    April 18, 2014   Volume 204, Issue 1-2 1-2 doi: 10.1016/j.vetpar.2014.04.010
Kornele M, O'Brien A, Phillippi-Taylor A, Marchiondo AA.No abstract available
Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses.
Veterinary anaesthesia and analgesia    April 16, 2014   Volume 42, Issue 1 17-29 doi: 10.1111/vaa.12165
Love EJ, Pelligand L, Taylor PM, Murrell JC, Sear JW.Describe the pharmacokinetics of buprenorphine and norbuprenorphine in horses and to relate the plasma buprenorphine concentration to the pharmacodynamic effects. Methods: Single phase non-blinded study. Methods: Six dedicated research horses, aged 3-10 years and weighing 480-515 kg. Methods: Thermal and mechanical nociceptive thresholds, heart and respiratory rates and locomotor activity were measured before and 15, 30, 45 & 60 minutes and 2, 4, 6, 8, 12 & 24 hours post-administration of 10 μg kg(-1) buprenorphine IV. Intestinal motility was measured 1, 6, 12 & 24 hours af...
Pharmacokinetics and bone resorption evaluation of a novel Cathepsin K inhibitor (VEL-0230) in healthy adult horses.
Journal of veterinary pharmacology and therapeutics    April 15, 2014   Volume 37, Issue 6 556-564 doi: 10.1111/jvp.12131
Hussein H, Ishihara A, Menendez M, Bertone A.Plasma pharmacokinetic (PK) and bone resorption biomarker [carboxy-terminal cross-linking telopeptide of type I collagen (CTX-1)] analyses were performed following single and multiple oral dose protocols of a Cathepsin K inhibitor (VEL-0230) in horses. Outcomes included plasma and urine drug and CTX-1 concentrations. In the dose range study, 2, 4, and 8 mg/kg body weight (b.w.) doses were administered in a Latin square design to three mares and evaluated for 1 week. Based on the PK characteristics of VEL-0230, 4 mg/kg b.w. was selected for the dose interval study in which 3.25 days (d) and 7 d...
International online survey to assess current practice in equine anaesthesia.
Equine veterinary journal    April 14, 2014   Volume 47, Issue 1 65-71 doi: 10.1111/evj.12257
Wohlfender FD, Doherr MG, Driessen B, Hartnack S, Johnston GM, Bettschart-Wolfensberger R.Multicentre Confidential Enquiries into Perioperative Equine Fatalities (CEPEF) have not been conducted since the initial CEPEF Phases 1-3, 20 years ago. Objective: To collect data on current practice in equine anaesthesia and to recruit participants for CEPEF-4. Methods: Online questionnaire survey. Methods: An online questionnaire was prepared and the link distributed internationally to veterinarians possibly performing equine anaesthesia, using emails, posters, flyers and an editorial. The questionnaire included 52 closed, semiclosed and open questions divided into 8 subgroups: demographic ...
Perioperative antimicrobials: should we be concerned about antimicrobial drug use in equine surgical patients?
Equine veterinary journal    April 11, 2014   Volume 46, Issue 3 267-269 doi: 10.1111/evj.12247
Southwood LL.No abstract available
Influence of laxatives on gastric emptying in healthy warmblood horses evaluated with the acetaminophen absorption test.
Berliner und Munchener tierarztliche Wochenschrift    April 4, 2014   Volume 127, Issue 3-4 170-175 
Snyder A, Koeller G, Seiwert B, Abraham G, Schusser GF.The use of laxatives is crucial in the treatment of horses with caecal or large colon impaction.To reach the large intestinal contents and resolve the impaction, laxatives must leave the stomach and pass through the small intestine.The aim of this study was to prove whether isotonic solutions of saline cathartics do not affect gastric emptying rate in contrast to hypertonic solutions. Six, fasted, healthy, adult Warmblood horses were used in a randomized study design with 1.8% sodium sulfate (1.8% Na2SO4), 4.2% magnesium sulfate (4.2% MgSO4), 25% sodium sulfate (25% Na2SO4), 25% magnesium sulf...
HPLC/ESI-MS(n) method for non-amino bisphosphonates: application to the detection of tiludronate in equine plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences    March 26, 2014   Volume 958 108-116 doi: 10.1016/j.jchromb.2014.03.018
Popot MA, Garcia P, Hubert C, Bolopion A, Bailly-Chouriberry L, Bonnaire Y, Thibaud D, Guyonnet J.Tiludronate is a non-nitrogen-containing biphosphonate drug approved in equine veterinary medicine for the treatment of navicular disease and bone sparvin in horse. Its hydrophilic properties and its strong affinity for the bone have made the control of its use quite difficult. After an initial step of method development in plasma and urine, due to a strong matrix effect and erratic detection in urine, the final method development was conducted in plasma. After addition of (3-trifluoromethylphenyl) thiomethylene biphosphonic acid as internal standard, automated sample preparation consisted of ...
Recovery of insulin sensitivity in mature horses after a 3 week course of dexamethasone therapy.
Equine veterinary journal    March 25, 2014   Volume 46, Issue 6 718-721 doi: 10.1111/evj.12242
Brennan KM, Urschel KL.Dexamethasone is an anti-inflammatory drug commonly used in equine medicine. Insulin sensitivity decreases with prolonged dexamethasone administration, but little information is available about the duration of this side effect after long-term treatment ends. Objective: To determine how long it takes for blood glucose, insulin and markers of insulin sensitivity to return to normal ranges after extended dexamethasone treatment has ceased. Methods: Experimental study. Methods: Eight healthy, mature, mixed-breed horses received 0.04 mg/kg bwt/day oral dexamethasone for 21 days. Blood samples wer...
Cholinesterase inhibitory triterpenoids from the bark of Garcinia hombroniana.
Journal of enzyme inhibition and medicinal chemistry    March 25, 2014   Volume 30, Issue 1 133-139 doi: 10.3109/14756366.2014.895720
Jamila N, Khairí·ªn M, Yeong KK, Osman H, Murugaiyah V.Context: Garcinia hombroniana Pierre, known as manggis hutan in Malaysia is a rich source of xanthones and benzophenones. Objective: This study was aimed to isolate and characterize potential cholinesterase inhibitors from the extracts of G. hombroniana bark and investigate their interactions with the enzymes. Methods: The dichloromethane extract afforded five triterpenoids which were characterized by NMR and mass spectral techniques. Cholinesterase inhibitory assay and molecular docking were performed to get insight of the inhibitory activity and molecular interactions of the compounds. The c...
The analysis of pergolide residues in horse plasma by LC with fluorescence detection.
Journal of AOAC International    March 22, 2014   Volume 96, Issue 6 1487-1493 doi: 10.5740/jaoacint.12-282
Doran G, Hughes K, Rendle D, Edwards S.Pergolide is used to treat pituitary pars intermedia dysfunction (equine Cushing's Disease), a neurodegenerative condition associated with loss of dopaminergic inhibition of the pituitary in horses. After oral administration, only low concentrations of the drug are achieved in plasma, making drug detection and quantification difficult. While direct analysis of plasma using sensitive MS/MS techniques is possible, dirty plasma samples and mobile phase buffers can cause instrumentation to become rapidly incapacitated. A method using LC with fluorescence detection was developed for pergolide analy...
Fosfomycin: Uses and potentialities in veterinary medicine.
Open veterinary journal    March 16, 2014   Volume 4, Issue 1 26-43 
Pérez DS, Tapia MO, Soraci AL.Fosfomycin (FOS) is a natural bactericidal broad-spectrum antibiotic which acts on proliferating bacteria by inhibiting cell wall and early murein/peptidoglycan synthesis. Bactericidal activity is evident against Gram positive and Gram negative bacteria and can also act synergistically with other antibiotics. Bacterial resistance to FOS may be natural or acquired. Other properties of this drug include inhibition of bacterial adhesion to epithelial cells, exopolysaccharide biofilm penetration, immunomodulatory effect, phagocytosis promotion and protection against the nephrotoxicity caused by ot...
Efficacy of omeprazole powder paste or enteric-coated formulation in healing of gastric ulcers in horses.
Journal of veterinary internal medicine    March 14, 2014   Volume 28, Issue 3 925-933 doi: 10.1111/jvim.12341
Birkmann K, Junge HK, Maischberger E, Wehrli Eser M, Schwarzwald CC.GastroGard, an omeprazole powder paste formulation, is considered the standard treatment for gastric ulcers in horses and is highly effective. Gastrozol, an enteric-coated omeprazole formulation for horses, has recently become available, but efficacy data are controversial and sparse. Objective: To investigate the efficacy of GastroGard and Gastrozol at labeled doses (4 and 1 mg of omeprazole per kg bwt, respectively, PO q24h) in healing of gastric ulcers. Methods: 40 horses; 9.5 ± 4.6 years; 491 ± 135 kg. Methods: Prospective, randomized, blinded study. Horses with an ulcer score ≥1 (Equi...
A pharmacokinetic/clinical approach to postulate a local action of intra-articular xylazine administration in the horse: a preliminary study.
Journal of veterinary pharmacology and therapeutics    March 8, 2014   Volume 37, Issue 5 464-471 doi: 10.1111/jvp.12110
Di Salvo A, Della Rocca G, Bazzica C, Giontella A, Cagnardi P, Nannarone S.The study aims to evaluate whether the analgesic effect of intra-articular (IA) route of xylazine administered to horses following arthroscopic surgery is due to a local or a systemic action. Two connected studies were performed. In the first, 1 mg/kg b.w. of xylazine was injected IA, and blood samples were taken to assess drug systemic absorption. In addition, systemic effects of the drug (sedation, ataxia or reduction of respiratory and cardiac rate) were registered. Control horses injected with saline IA were included in the study to exclude the influence of anaesthesia in the occurrence o...
Pharmacological characterization of muscarinic receptors in the contractions of isolated bronchi in the horse.
Journal of veterinary pharmacology and therapeutics    March 7, 2014   Volume 37, Issue 4 325-331 doi: 10.1111/jvp.12108
Menozzi A, Pozzoli C, Poli E, Delvescovo B, Serventi P, Bertini S.We investigated the effects of nonselective muscarinic antagonist (atropine) and of selective muscarinic subtype 1 (M1), 2 (M2), 3 (M3) antagonists (VU0255035, methoctramine, pFHHSiD, respectively) on the contractions evoked by electrical field stimulation (EFS) or by exogenous ACh in isolated horse bronchial muscle. Atropine completely inhibited neurogenic contractions in a concentration-dependent fashion, whereas selective muscarinic antagonists induced relevant modifications only at the highest concentration tested. Experiments with selective muscarinic antagonists in combination showed tha...
Stability of 1% voriconazole solution in a constant-rate infusion pump for topical ocular delivery to horses.
Veterinary ophthalmology    March 7, 2014   Volume 17 Suppl 1 82-89 doi: 10.1111/vop.12155
Smith KM, Maxwell L, Gull T, Payton ME, Gilmour MA.To establish the effect of storage in a constant-rate infusion (CRI) pump on the sterility and stability of voriconazole 1% solution. Methods: Nine vials of voriconazole (Vfend(®) I.V.) 1% solution were prepared. Approximately half of each solution was used to prime a commercially available CRI pump with attached subpalpebral lavage system (CRI/SPL unit) with the remaining solution stored in the commercial glass vial. Three CRI/SPL units and their three corresponding vials were stored at one of three temperatures: 23 °C, 33 °C, and 40 °C. The CRI pumps ran for 7 days, and the vials were st...
Antimicrobial use in foals: Do we need to change how we think?
Equine veterinary journal    February 20, 2014   Volume 46, Issue 2 137-138 doi: 10.1111/evj.12178
Haggett EF.No abstract available
Controlled nail delivery of a novel lipophilic antifungal agent using various modern drug carrier systems as well as in vitro and ex vivo model systems.
Journal of controlled release : official journal of the Controlled Release Society    February 18, 2014   Volume 180 60-70 doi: 10.1016/j.jconrel.2014.02.013
Naumann S, Meyer JP, Kiesow A, Mrestani Y, Wohlrab J, Neubert RH.The penetration behavior into human nails and animal hoof membranes of a novel antifungal agent (EV-086K) for the treatment of onychomycosis was investigated in this study. The new drug provides a high lipophilicity which is adverse for penetration into nails. Therefore, four different formulations were developed, with particular focus on a colloidal carrier system (CCS) due to its penetration enhancing properties. On the one hand, ex vivo penetration experiments on human nails were performed. Afterwards the human nail plates were cut by cryomicrotome in order to quantify the drug concentratio...
Preliminary pharmacokinetics of morphine and its major metabolites following intravenous administration of four doses to horses.
Journal of veterinary pharmacology and therapeutics    January 31, 2014   Volume 37, Issue 4 374-381 doi: 10.1111/jvp.12098
Knych HK, Steffey EP, McKemie DS.The objective of the current study was to describe the pharmacokinetics of morphine and its metabolites following intravenous administration to the horse. A total of eight horses (two per dose group) received a single intravenous dose of 0.05, 0.1, 0.2, or 0.5 mg/kg morphine. Blood samples were collected up to 72 h postdrug administration, analyzed using LC-MS/MS and pharmacokinetic parameters determined. Behavior, step counts, and gastrointestinal activity were also assessed. The beta and gamma half-life for morphine ranged from 0.675 to 2.09 and 6.70 to 18.1 h, respectively, following admini...
Determination of pergolide in horse plasma by UPLC-MS/MS for pharmacokinetic applications.
Journal of pharmaceutical and biomedical analysis    January 24, 2014   Volume 94 54-57 doi: 10.1016/j.jpba.2014.01.016
Jacobson GA, Pirie A, Edwards S, Hughes KJ, Rendle DI, Davies NW.Pergolide, an ergot-derived dopamine D2 receptor agonist, is used extensively as an orally administered treatment for pituitary pars intermedia dysfunction (PPID) in horses. One of the barriers associated with pergolide determinations in plasma for pharmacokinetic applications has been the technically demanding requirement for sensitivity. The objective of our work was to develop a simple assay for the determination of pergolide in plasma and demonstrate its potential application in the study of pergolide pharmacokinetics (PK) in horses. A UPLC-MS/MS assay was developed with a simple sample pr...
Detection of efaproxiral (RSR13) and its metabolites in equine by liquid chromatography tandem mass spectrometry.
Journal of mass spectrometry : JMS    January 22, 2014   Volume 49, Issue 1 57-67 doi: 10.1002/jms.3304
Yi R, Sandhu J, Zhao S, Lam G, Loganathan D, Morrissey B.Efaproxiral (RSR 13) is an experimental synthetic allosteric modifier of haemoglobin (Hb) that acts by increasing the release of oxygen from Hb to the surrounding tissues. It has been shown to increase maximum oxygen uptake (VO(2max)) in a canine skeletal muscle model. The ability to increase maximal muscle oxygen uptake makes efaproxiral a potential performance-enhancing agent and is therefore prohibited by the World Anti-Doping Agency. In this study, a method for the detection and elimination of efaproxiral in equine plasma and urine after a 2.5 g intravenous administration of efaproxiral ...
Use of oral sedatives in horses.
The Veterinary record    January 7, 2014   Volume 174, Issue 1 21 doi: 10.1136/vr.f7636
Chandler K, Bowen M.No abstract available
Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses.
Equine veterinary journal    January 7, 2014   Volume 46, Issue 6 729-733 doi: 10.1111/evj.12206
Davis JL, Kruger K, LaFevers DH, Barlow BM, Schirmer JM, Breuhaus BA.Angiotensin converting enzyme (ACE) inhibitors improve survival and quality of life in human patients and small animals with cardiovascular and renal disease. There is limited information regarding their effects in horses. Objective: The purpose of this study was to determine the pharmacokinetics of quinapril and its effects on ACE and renin in horses. Methods: Experimental study using healthy mature horses. Methods: Six healthy horses were administered quinapril at 120 mg i.v., 120 mg per os and 240 mg per os in a 3-way crossover design. Blood was collected for measurement of quinapril ...
Detection and pharmacokinetics of three formulations of firocoxib following multiple administrations to horses.
Equine veterinary journal    January 7, 2014   Volume 46, Issue 6 734-738 doi: 10.1111/evj.12211
Knych HK, Stanley SD, Arthur RM, Mitchell MM.The use of firocoxib in horses and its ability to affect performance and potential to allow a horse to compete when it otherwise should not, necessitates establishing appropriate withdrawal time guidelines prior to performance. Objective: To describe plasma concentrations and characterise the pharmacokinetics of 3 firocoxib formulations following multiple administrations of the label dose, with respect to recommended plasma thresholds for performance horses. Methods: Balanced 3-way crossover prospective study. Methods: Nine healthy mature horses were administered firocoxib injectable solution ...
Treatment of six cases of equine corneal stromal abscessation with intracorneal injection of 5% voriconazole solution.
Veterinary ophthalmology    January 6, 2014   Volume 17 Suppl 1 179-185 doi: 10.1111/vop.12136
Smith KM, Pucket JD, Gilmour MA.To describe a reproducible technique for intrastromal injection in the standing horse for treatment of corneal stromal abscessation. Methods: A retrospective clinical study addressing the history, treatment, and outcome of six equids (six eyes) that received intrastromal voriconazole injection. Methods: Equids having a deep stromal abscess suspected to be of fungal origin were administered intrastromal injection of 5% voriconazole solution under standing sedation in an effort to bring about enhanced resolution of clinical disease. Results: Intracorneal administration of 5% voriconazole solutio...
Naproxen in the horse: pharmacokinetics and side effects in the elderly.
Research in veterinary science    December 14, 2013   Volume 96, Issue 1 147-152 doi: 10.1016/j.rvsc.2013.12.007
Della Rocca G, Di Salvo A, Cagnardi P, Marchesi MC, Conti MB.It is well-known that old animals show physiologic and/or pathologic variation that could modify the pharmacokinetics of drugs and the related pharmacodynamic response. In order to define the most appropriate therapeutic protocol in old horses, pharmacokinetic profile and safety of naproxen were investigated in horses aged over 18 years after oral administration for 5 days at the dose of 10 mg/kg b.w./day. After the first administration, the maximum concentration (Cmax 44.21 ± 9.21 μg/mL) was reached at 2.5 ± 0.58 h post-treatment, the harmonic mean terminal half-life was 6.96 ± 1.73 h, AU...
The pharmacokinetics of glycopyrrolate in Standardbred horses.
Journal of veterinary pharmacology and therapeutics    December 11, 2013   Volume 37, Issue 3 260-268 doi: 10.1111/jvp.12085
Rumpler MJ, Colahan P, Sams RA.The disposition of plasma glycopyrrolate (GLY) is characterized by a three-compartment pharmacokinetic model after a 1-mg bolus intravenous dose to Standardbred horses. The median (range) plasma clearance (Clp), volume of distribution of the central compartment (V1 ), volume of distribution at steady-state (Vss), and area under the plasma concentration-time curve (AUC0-inf ) were 16.7 (13.6-21.7) mL/min/kg, 0.167 (0.103-0.215) L/kg, 3.69 (0.640-38.73) L/kg, and 2.58 (2.28-2.88) ng*h/mL, respectively. Renal clearance of GLY was characterized by a median (range) of 2.65 (1.92-3.59) mL/min/k...
Pharmacologic application of native GnRH in the winter anovulatory mare, I: frequency of reversion to the anovulatory state following ovulation induction and cessation of treatment.
Theriogenology    December 8, 2013   Volume 81, Issue 4 579-586 doi: 10.1016/j.theriogenology.2013.11.018
Thorson JF, Allen CC, Amstalden M, Williams GL.The continuous, subcutaneous infusion of native GnRH into seasonally anovulatory mares stimulates the synthesis and secretion of LH without pituitary refractoriness, offering opportunities to markedly accelerate the timing of ovulation within the operational breeding season. Herein, we tested the hypothesis that ovarian cycles induced in winter anovulatory mares using continuous administration of native GnRH for 28 days, beginning in either early February or early March (North America) would not revert to an anovulatory state after treatment withdrawal. Anovulatory mares received sham pumps (c...
Endometrial tissue and blood plasma concentration of ceftiofur and metabolites following intramuscular administration of ceftiofur crystalline free acid to mares.
Equine veterinary journal    December 6, 2013   Volume 46, Issue 5 606-610 doi: 10.1111/evj.12192
Scofield D, Black J, Wittenburg L, Gustafson D, Ferris R, Hatzel J, Traub-Dargatz J, McCue P.Systemic administration of ceftiofur crystalline free acid (CCFA) may be a potential treatment for infectious endometritis caused by Streptococcus equi ssp. zooepidemicus (S.  zooepidemicus) and other susceptible bacterial organisms in the mare. Objective: To determine if i.m. administration of CCFA at the label dose will exceed the minimum inhibitory concentration (MIC) of S.  zooepidemicus in the endometrium following single administration and multiple administration protocols. Methods: Experimental pharmacokinetic study. Methods: Three mares (Group 1) were administered a single i.m. dos...
Efficacy of ketamine hydrochloride administered as a basilar sesamoid nerve block in alleviating foot pain in horses caused by natural disease.
Equine veterinary journal    December 5, 2013   Volume 46, Issue 5 639-641 doi: 10.1111/evj.12188
Schumacher J, DeGraves F, Cesar F, Duran S.A local anaesthetic agent capable of temporarily resolving lameness after being administered perineurally would be helpful because rapid return of lameness would allow for other analgesic techniques to be performed within a short period of time. Objective: To determine if a 3% solution of ketamine hydrochloride (HCl), administered around the palmar nerves at the level of the base of the proximal sesamoid bones, can improve naturally occurring lameness that can be improved or abolished with a basilar sesamoid nerve block performed using lidocaine HCl and to compare the change in gait produced u...
Plasma and synovial fluid concentration of doxycycline following low-dose, low-frequency administration, and resultant inhibition of matrix metalloproteinase-13 from interleukin-stimulated equine synoviocytes.
Equine veterinary journal    December 5, 2013   Volume 46, Issue 2 198-202 doi: 10.1111/evj.12139
Maher MC, Schnabel LV, Cross JA, Papich MG, Divers TJ, Fortier LA.To determine whether low-dose, low-frequency doxycycline administration is capable of achieving chondroprotective concentrations within synovial fluid (SF) while remaining below minimum inhibitory concentration 90 (MIC90 ) of most equine pathogens and would be an option in the management of osteoarthritis. Objective: To determine whether low-dose, low-frequency oral administration of doxycycline can attain in vivo SF concentrations capable of chondroprotective effects through reduction of matrix metalloproteinase (MMP)-13 activity, while remaining below MIC90 of most equine pathogens. Method...
1 25 26 27 28 29 97